AA

Amol Ashok Gavande

Director Director DIN 09025796
DIN 09025796 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Ashok Gavande

Data last updated:

Amol Ashok Gavande was a Director at Lairus Pharma Private Limited (2022–2025) and Director at Chemnext Pharma Private Limited (from 2021). The companies operate in Pharma.

DIN 09025796
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2021
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lairus Pharma Private Limited U24290MH2022PTC387383
Director22 Jul 20222022₹4.8 Lakh (FY 2024)Active
Chemnext Pharma Private Limited U24290MH2021PTC353307
Director11 Jan 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemnext Pharma Private Limited
Lairus Pharma Private Limited
Premium access

Shareholding and investment profile for Amol Ashok Gavande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Ashok Gavande

Amol Ashok Gavande was first appointed on 11 Jan 2021 as Director at Chemnext Pharma Private Limited. The most recent appointment on record is 22 Jul 2022 at Lairus Pharma Private Limited.

Amol Ashok Gavande held 2 earlier board appointments: Lairus Pharma Private Limited (Director, 22 Jul 2022 to 25 Nov 2025); Chemnext Pharma Private Limited (Director, from 11 Jan 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available